The COVID-19 pandemic has illuminated and exacerbated challenges in caring for people of all ages with serious illness. The response to many of these challenges involved rapid innovation and as
The FDA Antimicrobial Drugs Advisory Committee (AMDAC) will convene on 30 November 2021 to discuss Merck and Ridgeback’s request for emergency use (EUA) of molnupiravir oral capsules for treatment of
The COVID-19 pandemic has illuminated and exacerbated challenges in caring for people of all ages with serious illness. The response to many of these challenges involved rapid innovation and as
A virtual science conference on One Health: Integrating Human, Animal and Environmental Health will be held 3 December 2021. The One Health movement, which has come to prominence in the
The NTP Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) is partnering with the Swiss Centre for Applied Human Toxicology and the Swiss State Secretariat for Economic Affairs
The National Biodefense Science Board (NBSB) will meet in public (virtually) on December 16, 2021, to provide advice and recommendations to ASPR regarding the development of the 2023-2026 National Health
The National Academies of Sciences, Engineering, and Medicine will convene a virtual workshop on January 14, 2022 to examine changes to diagnostic paradigms in response to the COVID-19 pandemic and
The National Academies will host a meeting 9-10 February 2022 to discuss the current understanding of animal welfare challenges in research on wildlife and biologically diverse vertebrate animal species. Research
The next public meeting of the National Biodefense Science Board (NBSB) will take place Monday, 7 March 2022 from 1:30pm – 3:00pm ET via Zoom. Join federal leaders, National Biodefense
